Syngene locks in Bristol Myers Squibb alliance through 2035
The expanded agreement significantly widens the scope of integrated services across the entire drug development lifecycle
The expanded agreement significantly widens the scope of integrated services across the entire drug development lifecycle
The company recorded revenue of Rs. 1,065 crore in the third quarter of FY26
The Eugene facility, with more than 20 years of history, houses a 16,000-square-foot R&D lab and a newly constructed 30,000-square-foot manufacturing facility
The updated closure system introduces intuitive handling, innovative functionality and a premium design compatible with a wide range of syringe formats
The collaboration gives Axolabs access to Codexis’ innovative RNA manufacturing technology
Pravesh brings with him over 29 years of experience in leading complex manufacturing operations and driving operational excellence
Transcenta will grant EirGenix a non-exclusive license to its Highly Intensified Continuous Bioprocessing (HiCB) platform
Additional investments planned to expand the site’s capacity and capabilities to support growing manufacturing programs
This partnership strengthens LMS as a leading CDMO supplier of peptide materials for both innovator and generic markets
Subscribe To Our Newsletter & Stay Updated